MedTrace Logo

Final Height in Patients With CH Diagnosed by the Screening

NCT04734457 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-10-05

No results posted yet for this study

Summary

The aim of this study is to evaluate longitudinal growth and final height in patients with Congenital Hypothyroidism detected by neonatal screening and factors affecting it.

Conditions

  • Congenital Hypothyroidism

Interventions

DRUG

Levothyroxin

We assess the effect of early diagnosis of CH by neonatal screening and start of treatment on the final height of the patients

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Wessam Mouharram, PhD · Ain Shams University

  • Rana Mahmoud, PhD · Ain Shams University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-02
Primary Completion
2022-03-01
Completion
2022-04-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04734457 on ClinicalTrials.gov